Mccormick & -md Stock Earnings Reports

McCormick and Unilever Foods announced a definitive combination to create a global flavor-focused company. The transaction is structured as a Reverse Morris Trust: Unilever Foods will receive a fixed number of McCormick shares (resulting in ~65% pro forma ownership for Unilever and its shareholders; McCormick shareholders ~35%) plus $15.7 billion cash. The deal implies an enterprise value of ~ $44.8 billion for Unilever Foods and was transacted at ~13.8x calendar 2025 EBITDA. Pro forma (2025) metrics: ~ $20 billion net sales and ~21% operating margin. Management expects approximately $600 million of annual run-rate cost synergies by year 3 (about two-thirds realized by end of year 2) and plans to reinvest roughly $100 million of incremental synergies into brand support and innovation. Combined company targets: sustainable organic sales growth of 3%–5% by year 3, operating margins of ~23%–25% as synergies flow through, and meaningful accretion to adjusted operating income and EPS in the first full year post-close. Financial policy: leverage expected at or below 4x net at closing, targeted to ~3x within two years, and continued commitment to dividends (consistent with historical payout behavior). Integration planning is underway with dedicated leadership, external advisers, and transitional service agreements (TSAs) to preserve business continuity; Unilever Foods’ India Foods business is excluded. Key near-term risks: required regulatory approvals, Unilever’s separation/carve-out process, execution risk on the multi-year integration and realization of projected synergies.